🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, and drug...
Status
Completed
Location
ICON Plc (PRA Health Sciences) - Netherlands
Start Date
2020-09-17
Trial ID
NCT04550195
Treatments Being Tested
This three-part study will evaluate the pharmacokinetics and bioavailabilit...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01654211
Treatments Being Tested
The purpose of this study is to evaluate how well LY4064912 is tolerated an...
Status
Active Not Recruiting
Location
Collaborative Neuroscience Network - CNS
Start Date
2025-08-28
Trial ID
NCT07152002
The purpose of this first-in-human (FIH) study is to evaluate safety, toler...
Status
Recruiting
Location
Quotient Sciences Sea View
Start Date
2025-11-20
Trial ID
NCT07235059
The purpose of this study is to assess the safety and tolerability of TMC64...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01202825
The researchers in this study want to learn how drug BAY2586116 works in pa...
Status
Completed
Location
Adelaide Institute for Sleep Health
Start Date
2020-02-04
Trial ID
NCT04236440
Treatments Being Tested
This is a Phase 1/2, randomized, double-blind, placebo-controlled, first-in...
Status
Recruiting
Location
Chris O'Brien Lifehouse
Start Date
2026-06-04
Trial ID
NCT07623525
In this trial, medicine NNC0560-0004 given in capsule form will be compared...
Status
Completed
Location
Northwick Park Hosptial
Start Date
2023-11-13
Trial ID
NCT06133270
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, drug lev...
Status
Terminated
Location
Medvin Clinical Research - Metyas
Start Date
2021-02-16
Trial ID
NCT04684654
Treatments Being Tested
The primary objective of this study is to assess the pharmacodynamic (PD) e...
Status
Completed
Location
Biotrial Inc
Start Date
2018-01-24
Trial ID
NCT03430661
Treatments Being Tested